Another large study including 1383 prostate cancer patients and 780 age-matched controls in Sweden revealed that the frequencies of the variant genotypes of TLR4 rs11536889 were significantly higher in patients (24.1%) than in controls (19.7%) [23]. Here, TLR4 is linked to prostate carcinoma.